{90 (insulin, regular, human 4 UNT Inhalation Powder [Afrezza]) / 90 (insulin, regular, human 8 UNT Inhalation Powder [Afrezza]) } Pack [Afrezza Titration Pack]
- RxCUI
- 1798388
- RxNorm name
- {90 (insulin, regular, human 4 UNT Inhalation Powder [Afrezza]) / 90 (insulin, regular, human 8 UNT Inhalation Powder [Afrezza]) } Pack [Afrezza Titration Pack]
- Display name
- {90 (insulin, regular, human 4 UNT Inhalation Powder [Afrezza]) / 90 (insulin, regular, human 8 UNT Inhalation Powder [Afrezza]) } Pack [Afrezza Titration Pack]
- Full name
- {90 (insulin, regular, human 4 UNT Inhalation Powder [Afrezza]) / 90 (insulin, regular, human 8 UNT Inhalation Powder [Afrezza]) } Pack [Afrezza Titration Pack]
- Term type
- BPCK
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:51
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 022472 | Afrezza | insulin human | 351(a) | Rx | 2026-07-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| AFREZZA | INSULIN HUMAN | Mannkind Corporation | 29f4637b-e204-425b-b89c-7238008d8c10 | 2026-05-30 | Boxed warning, Warnings, Adverse reactions | 1798388 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 29f4637b-e204-425b-b89c-7238008d8c10 | {90 (insulin, regular, human 4 UNT Inhalation Powder [Afrezza]) / 90 (insulin, regular, human 8 UNT Inhalation Powder [Afrezza]) } Pack [Afrezza Titration Pack] [BPCK] · afrezza 180 Inhalation Cartridge Titration Pack - 90 (4 UNT), 90 (8 UNT) [PSN] · Afrezza Titration Pack- 90 (4 UNT), 90 (8 UNT) [SY] | 3 | 16 | These highlights do not include all the information needed to use AFREZZA ® safely and effectively. See full prescribing information for AFREZZA. AFREZZA ® (insulin human) inhalation powder, for oral inhalation use Initial U.S. Approval: 2014 | 20260203 |